Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria

Rheumatology
J FransenPiet L C M van Riel

Abstract

To determine which cut-off point in the RA disease activity score (DAS28) corresponds to fulfilment of the ARA criteria for clinical remission. The disease activity of patients included in the Nijmegen RA inception cohort was systematically assessed every 3 months. For all visits, a modification of the ARA preliminary criteria for clinical remission was applied and the DAS28 was calculated. Receiver operating characteristic analysis was used to determine the cut-off point with maximum sensitivity and specificity in DAS28 corresponding with fulfilment of the modified ARA criteria. Three hundred and seventy-eight patients contributed 4378 visits. In 6.5% of the visits four of the five items and in 1.5% all five items of the modified ARA criteria were fulfilled. The optimal cut-off point for the DAS28 that corresponds to fulfilment of the modified ARA criteria was determined to be 2.66. DAS28 <2.6 corresponds to fulfilment of the preliminary ARA criteria for clinical remission in RA.

Citations

Apr 17, 2008·Clinical Rheumatology·Karin LaasMarjatta Leirisalo-Repo
May 27, 2010·Clinical Rheumatology·Hisham M HabibMohamed A Marie
May 8, 2013·Clinical Rheumatology·J J MalembaR Westhovens
Sep 16, 2005·The New England Journal of Medicine·Mark C GenoveseMaxime Dougados
Dec 19, 2012·Rheumatology·Vivian P Bykerk, Elena M Massarotti
Feb 7, 2007·Current Opinion in Rheumatology·Jenny E Heller, Nancy A Shadick
Oct 30, 2013·International Journal of Rheumatic Diseases·Geoffrey LittlejohnKathleen E Tymms
Feb 23, 2007·International Journal of Clinical Practice·D J ToddM E Weinblatt
Apr 30, 2005·Annals of the Rheumatic Diseases·D van der HeijdeUNKNOWN TEMPO Investigators
Jun 9, 2005·Annals of the Rheumatic Diseases·H MäkinenT Sokka
Dec 13, 2006·Annals of the Rheumatic Diseases·K ForslindUNKNOWN BARFOT Study Group
Mar 11, 2010·Annals of the Rheumatic Diseases·Josef S SmolenUNKNOWN T2T Expert Committee
Feb 1, 2011·Therapeutic Advances in Musculoskeletal Disease·Tajvur P SaberDouglas J Veale
Aug 22, 2012·Pediatric Rheumatology Online Journal·Philomine A van PeltNico M Wulffraat
Aug 29, 2012·Pediatric Rheumatology Online Journal·Philomien A van PeltNico M Wulffraat
Apr 1, 2009·BMC Medicine·Ronald F van Vollenhoven
Aug 2, 2006·Arthritis Research & Therapy·Annette H M van der Helm-van MilTom W J Huizinga
Jul 31, 2007·Arthritis Research & Therapy·Theresa KapralDaniel Aletaha
Oct 24, 2009·Arthritis Research & Therapy·Michel de BandtUNKNOWN STPR group of the French Society of Rheumatology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.